Shire: $400 million plant review not linked to Trump
Shire has informed some contractors that it is carrying out a review that is expected to last seven months on some key aspects of the work
Pharmaceutical giant Shire has said that a review of elements of its proposed new $400 million manufacturing plant in Meath are unconnected to concerns in its industry about the impact of Brexit or Donald Trump.
The London and New York-listed pharmaceutical company also insisted that despite launching a new review of “project design and scheduling”, this would not lead to a significant delay in the project, which was originally scheduled to begin construction ...
